Showing results (51-60 of 395) with videos related to
Sort By:
Pageof 40
European Journal of Pharmacology|September 19, 1996
Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertensionC Pilette, R Moreau, P Sogni, et al.Hepatology (Baltimore, Md.)|September 1, 1991
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosisY Bacq, C Gaudin, A Hadengue, et al.Liver|October 1, 1996
Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasisC Denié, F Vachiery, A Elman, et al.Nephron|January 1, 1993
Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failureR Moreau, C Gaudin, A Hadengue, et al.Gastroenterologie Clinique Et Biologique|January 1, 1992
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]R Moreau, O Soubrane, A Hadengue, et al.Journal of Hepatology|October 1, 1987
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and ratsS S Lee, A Hadengue, R Moreau, et al.Journal of Hepatology|September 1, 1989
Effects of oxygen inhalation on tissue oxygenation in patients with cirrhosis. Evidence for an impaired arterial baroreflex controlA Koshy, R Moreau, R Cerini, et al.Hepatology (Baltimore, Md.)|September 10, 1998
Effects of protein kinase C modulators on Na+/K+ adenosine triphosphatase activity and phosphorylation in aortae from rats with cirrhosisP Lahaye, K A Tazi, J P Rona, et al.Hepatology (Baltimore, Md.)|December 1, 1991
Relationships between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosisR Moreau, A Hadengue, E Pussard, et al.Journal of Hepatology|October 6, 1997
Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterationsF Vachiéry, R Moreau, A Hadengue, et al.Pageof 40